{"id":4638,"date":"2019-03-31T11:40:15","date_gmt":"2019-03-31T15:40:15","guid":{"rendered":"http:\/\/www.drugpatentwatch.com\/blog\/?p=4638"},"modified":"2024-12-11T21:43:54","modified_gmt":"2024-12-12T02:43:54","slug":"drugpatentwatch-in-the-news-the-biologic-patent-transparency-act","status":"publish","type":"post","link":"https:\/\/www.drugpatentwatch.com\/blog\/drugpatentwatch-in-the-news-the-biologic-patent-transparency-act\/","title":{"rendered":"DrugPatentWatch in the news: The Biologic Patent Transparency Act."},"content":{"rendered":"<p>For readers following the\u00a0the Biologic Patent Transparency Act, DrugPatentWatch has recently been cited in an article describing the act as &#8220;<a href=\"https:\/\/www.patentdocs.org\/2019\/03\/a-solution-in-search-of-a-problem.html\" data-cke-saved-href=\"https:\/\/www.patentdocs.org\/2019\/03\/a-solution-in-search-of-a-problem.html\">A Solution in Search of a Problem<\/a>.&#8221;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-4228\" src=\"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-300x300.jpg\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-300x300.jpg 300w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-100x100.jpg 100w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-600x600.jpg 600w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-64x64.jpg 64w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-150x150.jpg 150w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-768x768.jpg 768w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-1024x1024.jpg 1024w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop-640x640.jpg 640w, https:\/\/www.drugpatentwatch.com\/blog\/wp-content\/uploads\/2019\/01\/dpw_laptop.jpg 1751w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>In his <a href=\"https:\/\/www.patentdocs.org\/2019\/03\/a-solution-in-search-of-a-problem.html\" data-cke-saved-href=\"https:\/\/www.patentdocs.org\/2019\/03\/a-solution-in-search-of-a-problem.html\">article<\/a>, Patent Docs&#8217; Kevin Noonan explains the motivations to amend the way in which the Foood and Drug Administration approves biologic drugs. He argues that one of the justifications for the proposed legal changes &#8212; that it addresses a challenge faced by biosimilar applicants in identifying patents covering drugs is weakened because &#8220;&#8230;these concerns fly in the face of available outlets (for example,\u00a0<a href=\"http:\/\/www.drugpatentwatch.com\/\" data-cke-saved-href=\"http:\/\/www.drugpatentwatch.com\/\">www.drugpatentwatch.com<\/a>) that has this information readily available.&#8221;<\/p>\n<blockquote><p>But these concerns fly in the face of available outlets (for example,\u00a0<a href=\"http:\/\/www.drugpatentwatch.com\/\">www.drugpatentwatch.com<\/a>) that has this information readily available.<\/p>\n<h3 class=\"entry-header\"><a href=\"https:\/\/www.patentdocs.org\/2019\/03\/a-solution-in-search-of-a-problem.html\">A Solution in Search of a Problem<\/a><\/h3>\n<\/blockquote>\n<p>For more on follow-on biologics, see our blog posts at\u00a0<a href=\"https:\/\/www.drugpatentwatch.com\/blog\/predicting-patent-litigation-outcomes-for-biosimilars\/\" data-cke-saved-href=\"https:\/\/www.drugpatentwatch.com\/blog\/predicting-patent-litigation-outcomes-for-biosimilars\/\">Predicting Patent Litigation Outcomes for Biosimilars<\/a> and\u00a0<a href=\"https:\/\/www.drugpatentwatch.com\/blog\/exploring-biosimilars-as-a-drug-patent-strategy\/\" data-cke-saved-href=\"https:\/\/www.drugpatentwatch.com\/blog\/exploring-biosimilars-as-a-drug-patent-strategy\/\">Exploring Biosimilars as a Drug Patent Strategy<\/a>, and our deep database of biopharmaceutical business intelligence at <a href=\"https:\/\/www.DrugPatentWatch.com\" data-cke-saved-href=\"https:\/\/www.DrugPatentWatch.com\">www.DrugPatentWatch.com<\/a> .<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For readers following the\u00a0the Biologic Patent Transparency Act, DrugPatentWatch has recently been cited in an article describing the act as [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4228,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[],"class_list":["post-4638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights"],"modified_by":"DrugPatentWatch","_links":{"self":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/4638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/comments?post=4638"}],"version-history":[{"count":0,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/4638\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media\/4228"}],"wp:attachment":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media?parent=4638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/categories?post=4638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/tags?post=4638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}